Growing incidence of lifestyle-related diseases, coupled with high drug prices, are driving up healthcare costs at astounding rates in the Middle East…
Biosimilars are a relatively recent development in the pharmaceutical industry, meaning market penetration is still fairly low, even in many developed…
More than half of the top 20 pharma companies in Brazil are domestic, with Ache, EMS Farma, and Eurofarma taking the top three spots. Ranking is based…